Susan Hasty, Publisher
Table of Contents . . . February 14th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Vaccine Week | Other Publications
HIV/AIDS Research - Antibodies against HIV-1 V3 loop partially inhibit dendritic cell-SIGN binding
HIV/AIDS Research - siRNA targeted to the HIV-1 primer binding site can inhibit virus replication
HIV/AIDS Vaccine - Caveolin-1 binding domain of HIV glycoprotein is vaccine candidate
HIV/AIDS Vaccine - Infectious clone of pediatric HIV clade c isolate identified
HIV/AIDS Vaccine - Surface stability and immunogenicity of HIV envelope glycoprotein explored
HIV/AIDS Vaccines - Data advance knowledge in HIV/AIDS vaccines research
Business Update - Diagnostic technology company's HIV test remains choice of U.S hospitals
Diagnostics - Rapid test kit that detects HIV infection in 2 to 11 days released
Genomics - Scientists decipher two genomes of Cryptococcus neoformans
HIV Prevention - Healthcare worker HIV, hepatitis C protection procedures launched
HIV Vaccine - Pharmaceutical company begins second phase I clinical trial of HIV vaccine
HIV/AIDS Pathogenesis - Mechanisms for macrophage-mediated HIV-1 induction investigated
HIV/AIDS Prevention - NIAID begins enrolling volunteers for novel HIV vaccine study
HIV/AIDS Risk Factors - DC-SIGN promoter polymorphism increases risk of parenteral HIV-1 infection
HIV/AIDS Treatment - FDA, in an expedited review, approves generic AIDS drug combo
HIV/AIDS Treatment - Production on generic AIDS drug could begin in March
HIV/AIDS Vaccine - Cross-clade CD8 response to HIV-IIIB and Chinese B' and C/B' viruses reported
HIV/AIDS Vaccine - Determinants of HIV escape from primary cytotoxic T cell response
HIV/AIDS Vaccine - Glycoprotein-deficient rabies virus expressing SHIV envelope suppressed SHIV
HIV/AIDS Vaccine - Immunogenic consensus T helper epitopes for HIV vaccine engineered
HIV/AIDS Vaccine - Neutralization profiles of HIV-1 by monoclonal antibodies presented
HIV/AIDS Vaccine - Occult infection precedes immune response during vaginal SIV inoculations
HIV/AIDS Vaccine - Potential HIV/AIDS vaccine enters second stage of testing
HIV/AIDS Vaccine - Synapse formation enhances HIV transmission from dendritic to T cells
Influenza - National influenza vaccine summit stresses vaccination
Pediatric HIV/AIDS - Construction begins on pediatric HIV/AIDS medical center in Swaziland
Product Licensing - Pharma company obtains license to formulate HER-2 Protein AutoVac pharmaccine
Respiratory Syncytial Virus - Pharma company files IND with U.S. FDA for RSV vaccine
Vaccine Development - Malaria vaccine program expanded under U.S. NMRC contract
Vaccine Development - Research company awarded biodefense contract
Virology Vaccine - Inhibiting Arp2/3 complex limits infection of vaccinia virus and lentiviruses
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.